Full Text View
Tabular View
No Study Results Posted
Related Studies
Alcoholism and Schizophrenia: Effects of Clozapine
This study has been terminated.
Study NCT00169026   Information provided by Dartmouth-Hitchcock Medical Center

First Received on September 10, 2005.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Dual Diagnosis
Schizoaffective Disorder
Psychotic Disorder
Substance Abuse
Alcohol Abuse
Additional conditions recognized in this trial
Alcoholism
Mental Disorders
Psychotic Disorders
Substance-Related Disorders
More general conditions related to this trial
Alcohol-Related Disorders
Schizophrenia and Disorders with Psychotic Features
Additional drug interventions recognized in this trial
Antipsychotic Agents
Clozapine
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Dartmouth-Hitchcock Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Harvard Medical School
Commonwealth Research Center, Massachusetts
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services